Abstract: A resist material is combined with a ligand containing four or more fluorine atoms and is represented by the following formula: [(R1M)iOjXk(OH)m] (OH)nR2p, wherein one of “R1” and “R2” is CaFbHc, CaFbHcNd, CaFbHcPd, CaFbHcSd, CaFbHcOd, CaFbHcNdSe, CaFbHcPdSe, CaFbHcNdOe, or CaFbHcPdOe, the other of “R1” and “R2” is CaHc, CaFbHc, CaFbHcNd, CaFbHcPd, CaFbHcSd, CaFbHcOd, CaFbHcNdSe, CaFbHcPdSe, CaFbHcNdOe, or CaFbHcPdOe, “a” and “c” are each independently an integer of 0 to 20, “b” is an integer of 4 to 30, “d” and “e” are each independently an integer of 0 to 5, “M” is one metal selected from a specified list, “i” is an integer from 1 to 12, “j” is an integer of 1 to 14, “X” is a halogen selected from a specified list, “k” and “m” are each independently an integer of 0 to 6, and “n” and “p” are each independently an integer of 0 to 2.

Abstract: Disclosed are an ink for photonic annealing, a thick metal film surface-functionalized using the ink for photonic annealing, and methods of manufacturing the ink for photonic annealing and the thick metal film. More particularly, the ink for photonic annealing includes metal micron particles; and metal nanoparticles adsorbed on the surface of the metal micron particles, wherein the adsorbed metal nanoparticles are formed in a single layer through surface modification.

Abstract: The present invention relates to a composition for preventing sleep disorders or insomnia, containing an enzyme-treated Ashwagandha extract as an active ingredient, and specifically, since it was confirmed that in an animal model and a sleep disorder animal model, which were administered an enzyme-treated Ashwagandha extract, sleep latency and awake time during sleep were decreased, sleep time, non-rapid eye movement (NREM) sleep time and ?-waves were increased, and as a result, sleep activity was improved, the enzyme-treated Ashwagandha extract can be used as an active ingredient of a composition for preventing or treating sleep disorders or insomnia.

Abstract: A semiconductor device includes a die pad, a bond post, a die disposed over the die pad, a wire coupled between the die and the bond post and having a first portion bonded to the die at a first bond area and a second portion bonded to the bond post at a second bond area, a first bonding cover disposed over the first portion, and a second bonding cover disposed over the second portion. A method includes bonding a first portion of a wire to a die at a first bond area, bonding a second portion of the wire to a first bond post of a lead frame at a second bond area, applying a bonding material over the first bond area to form a first bonding cover, and applying the bonding material over the second bond area to form a second bonding cover.

Abstract: Disclosed is a support unit for supporting a substrate. The support unit includes a support plate having an inner space defined therein, a heating member disposed in the inner space and emitting light for heating the substrate supported on the support unit, and a reflective member disposed along an edge region of the support plate and reflecting thermal energy of the light to an edge region of the substrate supported on the support unit.

Abstract: Disclosed is an electrolyte membrane including an antioxidant containing elemental sulfur or a sulfur compound to improve antioxidant activity and resistance to acids. In addition, a membrane-electrode assembly including the electrolyte membrane is disclosed.

Abstract: Provided a display panel and a display device. The display panel has a first display region including a light-transmitting region. The display panel includes a display function layer including light-emitting elements, a color filter layer arranged on a side of the display function layer facing towards a display surface of the display panel, and auxiliary structures that are nonopaque and arranged on the side of the display function layer facing towards the display surface of the display panel. The color filter layer includes color resists corresponding to the light-emitting elements. The auxiliary structure is at least located between adjacent color resists, and overlaps with the light-transmitting region. The display device includes the display panel.

Abstract: A method and a device for compensating for sensor drift are disclosed. A method for compensating for sensor drift, according to one embodiment, comprises the steps of: confirming the suitability of sensor data; defining a transformation model for transforming the sensor data; setting a loss function on the basis of the transformation model; and optimizing the transformation model on the basis of the loss function.

Abstract: A genetically engineered live bacterium comprising at least one effector gene that encodes a medical effector and at least one gene modification that shortens the bacterium's lifespan. After being administered to a subject, the bacterium survives within a time sufficient to allow the medical effector to exert at least one medical action and dies within a time sufficient to minimize pathogenesis to the subject. The bacterium provides an effective treatment of diseases or improving conditions while ensuring the biosafety for medical use.

Abstract: An apparatus for treating a substrate includes a process chamber having a treatment space defined therein, a support unit for supporting the substrate in the treatment space, a liquid supply unit for supplying treating liquid to the substrate supported on the support unit, and a heating unit disposed in the support unit for heating the substrate supported on the support unit, wherein the heating unit includes a plurality of lamps to heat the substrate, and a window disposed above the lamps to transmit light emitted from the lamps, wherein the window includes a base in a form of a plate, and light adjustment means formed on the base to spread or converge light emitted from the lamps.

Abstract: A memory device, and an operating method of the memory device and a host device are provided. The method of operating a memory device includes receiving a command for requesting an Eye Open Monitor (EOM) operation performance from a host device, receiving pattern data including data and non-data from the host device, performing the EOM operation which performs an error count to correspond to the data, and does not perform the error count on the non-data, and transmitting an EOM response signal including the error count result to the host device.

Abstract: The present invention relates to methods of overcoming the resistance to an EGFR (Epidermal Growth Factor Receptor)-targeting antibody through a peptide that binds specifically to neuropilin-1 (NRP1). The NRP1-specific binding-fused EGFR-targeting antibody according to the present invention is highly effective in the treatment of various tumors resistant to EGFR-targeting antibody alone.

Abstract: One embodiment of the present invention relates to a cylindrical secondary battery. The present invention comprises: an electrode assembly comprising a negative electrode plate, a positive electrode plate, and a separator interposed between the negative electrode plate and the positive electrode plate, and having a wound shape in one direction; a metallic finishing tape attached to the outer peripheral surface of the electrode assembly so as to cover at least a portion of the electrode assembly; a cylindrical can having one side opened so as to accommodate the electrode assembly along with an electrolyte; and a cap assembly coupled to the open one side of the can so as to seal the can. According to the present invention, by applying the metallic tape to a winding finishing portion of the electrode assembly, the effect is gained of improving the dispersion of quality of a substrate finishing structure, caused by the dispersion of a major axis.

Abstract: The present invention relates to the development of a composition for the treatment of novel SARS-coronavirus-2 infection. The drug efficacy was evaluated through CPE (Cytopathic Effect)-based assay method that measures how long the cells survive by infecting SARS-CoV-2 after receiving a drug library previously approved as a treatment for a specific disease from the Korea Chemical Bank and treating Vero cells with the drug, and an image-based assay that measures how much virus is reduced in infected cells. Through this, 16 kinds of drugs effective in the treatment of SARS-CoV-2 were re-positioned.

Abstract: Provided is a composition for treating coronavirus disease-19 (Corona19, COVID-19), including a phenanthroindolizidine and phenanthroquinolizidine alkaloid derivative compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof as an active ingredient. According to the presently claimed subject matter, the phenanthroindolizidine and phenanthroquinolizidine alkaloid derivative compound has excellent antiviral activity against COVID-19, and therefore can be effectively used as a composition for treating SARS coronavirus infection including COVID-19.

Abstract: The present invention relates to a composition for preventing sleep disorders or insomnia, containing an enzyme-treated Ashwagandha extract as an active ingredient, and specifically, since it was confirmed that in an animal model and a sleep disorder animal model, which were administered an enzyme-treated Ashwagandha extract, sleep latency and awake time during sleep were decreased, sleep time, non-rapid eye movement (NREM) sleep time and ?-waves were increased, and as a result, sleep activity was improved, the enzyme-treated Ashwagandha extract can be used as an active ingredient of a composition for preventing or treating sleep disorders or insomnia.

Abstract: Provided is a bacteria for targeting tumors and treating cancer, a drug delivery composition, and methods of using same for treating cancer.

Abstract: A wafer treatment apparatus includes a wafer supporter for supporting and rotating a wafer, a frontside liquid discharger for discharging a liquid toward a frontside of the wafer, a backside liquid discharger for discharging the liquid toward a backside of the wafer, a treatment chamber for accommodating the wafer supporter, and including liquid collecting inlets stacked on each other and receiving the liquid discharged from at least one of the frontside and backside liquid dischargers, and a controller for controlling a height of an upper end of a first liquid collecting inlet of the liquid collecting inlets to have one of a first height in a process of discharging the liquid to the backside of the wafer adjacent to the wafer supporter and a second height, lower than the first height, in a process of discharging the liquid to the frontside of the wafer.

Abstract: The present invention relates to a heterodimeric Fc-fused protein comprising a first Fc region and a second Fc region of an immunoglobulin Fc pair and a physiologically active protein composed of two or more different subunits, wherein one or more subunits of the physiologically active protein are linked separately to one or more ends of the N-terminus or C-terminus of the first Fc region and/or the second Fc region, and CH3 domains of the first Fc region and the second Fc region are mutated so as to promote the heterodimeric Fc formation. Moreover, the present invention relates to a pharmaceutical composition comprising the heterodimeric Fc-fused protein.

Abstract: An apparatus for treating a substrate of the present invention includes a buffer unit, an inversion unit, a first transfer chamber, a second transfer chamber, a first cleaning chamber, and a second cleaning chamber. The first transfer chamber, the inversion unit, and the second transfer chamber are sequentially arranged in one direction. The first cleaning chamber is disposed at one side of the first transfer chamber, and the second cleaning chamber is disposed at one side of the second transfer chamber. A first main transfer robot provided in the first transfer chamber directly transfers the substrate between the buffer unit, the inversion unit, and the first cleaning chamber. The second main transfer robot provided in the second transfer chamber directly transfers the substrate between the buffer unit, the inversion unit, and the second cleaning chamber.